Literature DB >> 25487859

Base modification strategies to modulate immune stimulation by an siRNA.

Rachel Anne P Valenzuela1, Scott R Suter, Alexi A Ball-Jones, José M Ibarra-Soza, Yuxuan Zheng, Peter A Beal.   

Abstract

Immune stimulation triggered by siRNAs is one of the major challenges in the development of safe RNAi-based therapeutics. Within an immunostimulatory siRNA sequence, this hurdle is commonly addressed by using ribose modifications (e.g., 2'-OMe or 2'-F), which results in decreased cytokine production. However, as immune stimulation by siRNAs is a sequence-dependent phenomenon, recognition of the nucleobases by the trigger receptor(s) is also likely. Here, we use the recently published crystal structures of Toll-like receptor 8 (TLR8) bound to small-molecule agonists to generate computational models for ribonucleotide binding by this immune receptor. Our modeling suggested that modification of either the Watson-Crick or Hoogsteen face of adenosine would disrupt nucleotide/TLR8 interactions. We employed chemical synthesis to alter either the Watson-Crick or Hoogsteen face of adenosine and evaluated the effect of these modifications in an siRNA guide strand by measuring the immunostimulatory and RNA interference properties. For the siRNA guide strand tested, we found that modifying the Watson-Crick face is generally more effective at blocking TNFα production in human peripheral blood mononuclear cells (PBMCs) than modification at the Hoogsteen edge. We also observed that modifications near the 5'-end were more effective at blocking cytokine production than those placed at the 3'-end. This work advances our understanding of how chemical modifications can be used to optimize siRNA performance.
© 2015 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  TLR8; immune stimulation; nucleobase modification; siRNA; toll-like receptors

Mesh:

Substances:

Year:  2014        PMID: 25487859      PMCID: PMC4337945          DOI: 10.1002/cbic.201402551

Source DB:  PubMed          Journal:  Chembiochem        ISSN: 1439-4227            Impact factor:   3.164


  34 in total

1.  Sequence-specific potent induction of IFN-alpha by short interfering RNA in plasmacytoid dendritic cells through TLR7.

Authors:  Veit Hornung; Margit Guenthner-Biller; Carole Bourquin; Andrea Ablasser; Martin Schlee; Satoshi Uematsu; Anne Noronha; Muthiah Manoharan; Shizuo Akira; Antonin de Fougerolles; Stefan Endres; Gunther Hartmann
Journal:  Nat Med       Date:  2005-02-20       Impact factor: 53.440

2.  Widespread siRNA "off-target" transcript silencing mediated by seed region sequence complementarity.

Authors:  Aimee L Jackson; Julja Burchard; Janell Schelter; B Nelson Chau; Michele Cleary; Lee Lim; Peter S Linsley
Journal:  RNA       Date:  2006-05-08       Impact factor: 4.942

Review 3.  Deciphering the code of innate immunity recognition of siRNAs.

Authors:  Mouldy Sioud
Journal:  Methods Mol Biol       Date:  2009

4.  Conformer generation with OMEGA: learning from the data set and the analysis of failures.

Authors:  Paul C D Hawkins; Anthony Nicholls
Journal:  J Chem Inf Model       Date:  2012-11-12       Impact factor: 4.956

5.  Synthetic TLR agonists reveal functional differences between human TLR7 and TLR8.

Authors:  Keith B Gorden; Kevin S Gorski; Sheila J Gibson; Ross M Kedl; William C Kieper; Xiaohong Qiu; Mark A Tomai; Sefik S Alkan; John P Vasilakos
Journal:  J Immunol       Date:  2005-02-01       Impact factor: 5.422

6.  Single-stranded small interfering RNA are more immunostimulatory than their double-stranded counterparts: a central role for 2'-hydroxyl uridines in immune responses.

Authors:  Mouldy Sioud
Journal:  Eur J Immunol       Date:  2006-05       Impact factor: 5.532

7.  7-Substituted 8-aza-7-deazaadenosines for modification of the siRNA major groove.

Authors:  José M Ibarra-Soza; Alexi A Morris; Prasanna Jayalath; Hayden Peacock; Wayne E Conrad; Michael B Donald; Mark J Kurth; Peter A Beal
Journal:  Org Biomol Chem       Date:  2012-07-05       Impact factor: 3.876

8.  Cationic liposome-mediated delivery of siRNAs in adult mice.

Authors:  Mouldy Sioud; Dag R Sørensen
Journal:  Biochem Biophys Res Commun       Date:  2003-12-26       Impact factor: 3.575

9.  Activation of the interferon system by short-interfering RNAs.

Authors:  Carol A Sledz; Michelle Holko; Michael J de Veer; Robert H Silverman; Bryan R G Williams
Journal:  Nat Cell Biol       Date:  2003-08-24       Impact factor: 28.824

10.  Click modification of RNA at adenosine: structure and reactivity of 7-ethynyl- and 7-triazolyl-8-aza-7-deazaadenosine in RNA.

Authors:  Kelly J Phelps; José M Ibarra-Soza; Kiet Tran; Andrew J Fisher; Peter A Beal
Journal:  ACS Chem Biol       Date:  2014-06-16       Impact factor: 5.100

View more
  8 in total

1.  TLR8 activation and inhibition by guanosine analogs in RNA: Importance of functional groups and chain length.

Authors:  Tiannan Hu; Scott R Suter; Madeline M Mumbleau; Peter A Beal
Journal:  Bioorg Med Chem       Date:  2017-11-11       Impact factor: 3.641

Review 2.  RNA interference-based therapy and its delivery systems.

Authors:  Xiuhui Chen; Lingegowda S Mangala; Cristian Rodriguez-Aguayo; Xianchao Kong; Gabriel Lopez-Berestein; Anil K Sood
Journal:  Cancer Metastasis Rev       Date:  2018-03       Impact factor: 9.264

3.  Safety of Striatal Infusion of siRNA in a Transgenic Huntington's Disease Mouse Model.

Authors:  Emily Johnson; Kathryn Chase; Sarah McGowan; Erica Mondo; Edith Pfister; Eric Mick; Randall H Friedline; Jason K Kim; Ellen Sapp; Marian DiFiglia; Neil Aronin
Journal:  J Huntingtons Dis       Date:  2015

Review 4.  Therapeutic siRNA: state of the art.

Authors:  Bo Hu; Liping Zhong; Yuanyu Huang; Yuhua Weng; Ling Peng; Yongxiang Zhao; Xing-Jie Liang
Journal:  Signal Transduct Target Ther       Date:  2020-06-19

5.  Nucleotide Modifications Decrease Innate Immune Response Induced by Synthetic Analogs of snRNAs and snoRNAs.

Authors:  Grigory Stepanov; Evgenii Zhuravlev; Victoria Shender; Anna Nushtaeva; Evgenia Balakhonova; Elena Mozhaeva; Marat Kasakin; Vladimir Koval; Alexander Lomzov; Marat Pavlyukov; Irina Malyants; Mikhail Zhorov; Tatyana Kabilova; Elena Chernolovskaya; Vadim Govorun; Elena Kuligina; Dmitry Semenov; Vladimir Richter
Journal:  Genes (Basel)       Date:  2018-11-02       Impact factor: 4.096

Review 6.  Therapeutic siRNA: State-of-the-Art and Future Perspectives.

Authors:  Maik Friedrich; Achim Aigner
Journal:  BioDrugs       Date:  2022-08-23       Impact factor: 7.744

Review 7.  Progress and Prospects of Anti-HBV Gene Therapy Development.

Authors:  Mohube B Maepa; Ilke Roelofse; Abdullah Ely; Patrick Arbuthnot
Journal:  Int J Mol Sci       Date:  2015-07-31       Impact factor: 5.923

8.  RNAs Containing Modified Nucleotides Fail To Trigger RIG-I Conformational Changes for Innate Immune Signaling.

Authors:  Ann Fiegen Durbin; Chen Wang; Joseph Marcotrigiano; Lee Gehrke
Journal:  mBio       Date:  2016-09-20       Impact factor: 7.867

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.